Creative Medical Technology Holdings Inc (CELZ)

[Gobsmacked01]

Here are some thoughts I've had and what I'm waiting for (THESE NEXT 2 WEEKS START AN EXCITING TIME FOR US. IMO):

- In the next few weeks we get the 2018 summary to include Q4 financials we were told might contain deferred income from Q3. This will take some days to digest and get folks attention, but the ad showing on this message board will help with increased awareness.

- Starting today, our 52 week low is no longer .0025 and over the next several weeks the 52 week low will gradually be shown to be very near where we are now. This will have an effect, imo, on the technical analysis of folks in a way that may increase interest in our ticker.

- We may soon be told when our peer reviewed clinical trial will be published. My impression from that recent PR was that the peer review could be complete and finished product might be in the process of being shopped around for publication. I think this might occur in May. Strategically, we will have marketed to the 16000 or so Urologists directly and with a published peer reviewed clinical trial would we even need to attend that convention? Urologists present should already be aware of us and several may already be offering our procedure.

- In May, possibly coinciding with our peer reviewed clinical trial publication, we should see Q1 2019 financials posted. Combined with our adjusted technical analysis we could look VERY favorable when considering / comparing to Q1 2018 year over year revenue increases.

- I suspect June is when we start hearing more specifics about other IP in our pipeline being developed using revenue from CaverStem / FemCELZ as has already been forecasted. We may hear international CaverStem / FemCELZ news as well.

- I view July as a 'dead' month where investors sell off to pay for vacations, etc... This will be a buy opportunity, imo, especially depending on what August looks like.

- Check out who was contributing to this for Osteoarthritis:
http://pr.report/JG5uEsSq
and this for COPD:
https://www.jocmr.org/index.php/JOCMR/article/view/3072/1877
And this for critical limb ischemia:
https://www.jocmr.org/index.php/JOCMR/article/view/3072/1877

I think T. Ichim from CELZ and Kristen Comella of US$M fame may have worked together before. I heard sometime around August is when the DOJ/FDA mediation with US$M may occur. I think its possible the FDA may determine that our CELZ folks providing an FDA compliant ED Stem Cell solution called CaverStem / FemCELZ already in the marketplace could mean US$M will need to agree to NOT provide adipose derived ED solutions in any of their 750 clinics nationwide...I don't want to start a rumor, here, but I get the impression US$M folks may have T. Ichim's cell phone number and might use it around August to discuss offering CaverStem / FemCELZ procedures within their clinics and affiliates... Just a thought, but that could represent a busy August for us.

What does anyone else think?

-Go CELZ$$$$